Soros Fund Management’s Immunovant IMVT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-140,000	Closed	-$5.9M	–	192
2023 Q4	$5.9M	Buy	140,000 +65,000	+87%	+$2.74M	0.08%	110
2023 Q3	$2.88M	Buy	+75,000	New	+$2.88M	0.04%	134